Clinical trial
The COREG And Lisinopril Combination Therapy In Hypertensive Subjects (COSMOS)…
NCT00347360 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00347360 |
|---|---|
| Title | The COREG And Lisinopril Combination Therapy In Hypertensive Subjects (COSMOS) Trial |
| Official title | A Randomized, Double-Blind, Double-Dummy, Parallel Group, Factorial Design Trial to Assess the Efficacy and Safety of up to Six Weeks Treatment With 20mg, 40mg, or 80mg QD Doses of Carvedilol Controlled Release Formulation (COREG CR) or 10mg, 20mg, or 40mg QD Doses of Lisinopril (Zestril) or a… |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | lisinopril, carvedilol controlled release formulation |
| Enrollment | 654 |
| Start date | Jul 1, 2006 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | Jul 4, 2006 |
| Last update posted | Dec 26, 2016 |
| Countries | United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: